In breast cancer, tumor-initiating cancer stem cells express CD44, a transmembrane receptor for hyaluronic acid that is a known effector of metastasis, and maintain low levels of CD24, a sialoglycoprotein that facilitates a number of important signaling networks in development28–32. The gene discussed is CD44; the disease is neoplasm.